Artwork

Content provided by Prateek Joshi. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Prateek Joshi or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Biochemistry AI

44:02
 
Share
 

Manage episode 384125778 series 3370867
Content provided by Prateek Joshi. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Prateek Joshi or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Nicolas Tilmans is the cofounder and CEO of Anagenex, an AI-powered drug discovery platform. They have raised $37M in funding so far from investors such as Lux Capital, Khosla Ventures, Air Street, Menlo, and Catalio. He was previously the VP of Engineering at Lumiata. He has a PhD in Biochemistry from Stanford.
In this episode, we cover a range of topics including:
- What are small molecule drugs and why are they challenging to develop
- The founding of Anagenex
- Data generation engine
- DNA Encoded Libraries (DELs)
- Affinity Selected Mass Spectrometry
- Identifying the right targets
- What's next for AI-infused drug discovery
Nicolas's favorite books:
- Tomorrow, and Tomorrow, and Tomorrow (Author: Gabrielle Zevin)
- Letters by Abraham Lincoln (Author: Abraham Lincoln)
--------
Where to find Prateek Joshi:
Newsletter: https://prateekjoshi.substack.com
Website: https://prateekj.com
LinkedIn: https://www.linkedin.com/in/prateek-joshi-91047b19
Twitter: https://twitter.com/prateekvjoshi

  continue reading

152 episodes

Artwork

Biochemistry AI

Infinite ML with Prateek Joshi

14 subscribers

published

iconShare
 
Manage episode 384125778 series 3370867
Content provided by Prateek Joshi. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Prateek Joshi or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Nicolas Tilmans is the cofounder and CEO of Anagenex, an AI-powered drug discovery platform. They have raised $37M in funding so far from investors such as Lux Capital, Khosla Ventures, Air Street, Menlo, and Catalio. He was previously the VP of Engineering at Lumiata. He has a PhD in Biochemistry from Stanford.
In this episode, we cover a range of topics including:
- What are small molecule drugs and why are they challenging to develop
- The founding of Anagenex
- Data generation engine
- DNA Encoded Libraries (DELs)
- Affinity Selected Mass Spectrometry
- Identifying the right targets
- What's next for AI-infused drug discovery
Nicolas's favorite books:
- Tomorrow, and Tomorrow, and Tomorrow (Author: Gabrielle Zevin)
- Letters by Abraham Lincoln (Author: Abraham Lincoln)
--------
Where to find Prateek Joshi:
Newsletter: https://prateekjoshi.substack.com
Website: https://prateekj.com
LinkedIn: https://www.linkedin.com/in/prateek-joshi-91047b19
Twitter: https://twitter.com/prateekvjoshi

  continue reading

152 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide